MANNKIND CORP Shares Outstanding (Cover Page)
MANNKIND CORP (MNKD) had Shares Outstanding (Cover Page) of 321.54 million shares as of 2026-07-24, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-24: Entity Common Stock, Shares Outstanding 321.54M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 308.95M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 308.10M shares.
- 2025-10-24: Entity Common Stock, Shares Outstanding 307.07M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-24 | 321.54M shares 10-Q · filed 2026-08-05 |
| 2026-04-24 | 308.95M shares 10-Q · filed 2026-05-06 |
| 2026-02-13 | 308.10M shares 10-K · filed 2026-02-26 |
| 2025-10-24 | 307.07M shares 10-Q · filed 2025-11-05 |
| 2025-07-25 | 306.83M shares 10-Q · filed 2025-08-06 |
| 2025-04-25 | 303.93M shares 10-Q · filed 2025-05-08 |
| 2025-02-14 | 303.59M shares 10-K · filed 2025-02-26 |
| 2024-10-25 | 275.78M shares 10-Q · filed 2024-11-07 |
| 2024-07-26 | 275.00M shares 10-Q · filed 2024-08-07 |
| 2024-04-26 | 272.32M shares 10-Q · filed 2024-05-08 |
| 2024-02-16 | 270.42M shares 10-K · filed 2024-02-27 |
| 2023-10-27 | 269.57M shares 10-Q · filed 2023-11-07 |
| 2023-07-28 | 268.36M shares 10-Q · filed 2023-08-07 |
| 2023-04-28 | 264.31M shares 10-Q · filed 2023-05-09 |
| 2023-02-10 | 263.92M shares 10-K · filed 2023-02-23 |
| 2022-10-28 | 263.20M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 257.34M shares 10-Q · filed 2022-08-09 |
| 2022-04-29 | 252.57M shares 10-Q · filed 2022-05-05 |
| 2022-02-11 | 251.80M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 251.26M shares 10-Q · filed 2021-11-09 |
| 2021-07-30 | 249.66M shares 10-Q · filed 2021-08-11 |
| 2021-04-30 | 249.16M shares 10-Q · filed 2021-05-12 |
| 2021-02-12 | 247.16M shares 10-K · filed 2021-02-25 |
| 2020-10-26 | 232.60M shares 10-Q · filed 2020-11-04 |
| 2020-07-13 | 229.17M shares 10-Q · filed 2020-08-05 |
| 2020-04-13 | 213.14M shares 10-Q · filed 2020-05-06 |
| 2020-02-13 | 212.30M shares 10-K · filed 2020-02-25 |
| 2019-10-31 | 206.41M shares 10-Q · filed 2019-11-08 |
| 2019-07-16 | 189.62M shares 10-Q · filed 2019-08-07 |
| 2019-04-15 | 187.78M shares 10-Q · filed 2019-05-07 |
| 2019-02-14 | 187.34M shares 10-K · filed 2019-02-26 |
| 2018-10-22 | 159.60M shares 10-Q · filed 2018-11-01 |
| 2018-07-17 | 152.99M shares 10-Q · filed 2018-08-02 |
| 2018-04-24 | 140.03M shares 10-Q · filed 2018-05-09 |
| 2018-02-09 | 120.47M shares 10-K · filed 2018-02-27 |
| 2017-10-31 | 117.15M shares 10-Q · filed 2017-11-07 |
| 2017-08-01 | 104.68M shares 10-Q · filed 2017-08-07 |
| 2017-05-05 | 101.01M shares 10-Q · filed 2017-05-10 |
| 2017-03-10 | 95.78M shares 10-K · filed 2017-03-16 |
| 2016-11-01 | 478.38M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 478.05M shares 10-Q/A · filed 2016-08-10 |
| 2016-05-02 | 429.16M shares 10-Q · filed 2016-05-09 |
| 2016-02-22 | 428.85M shares 10-K · filed 2016-03-15 |
| 2015-11-02 | 409.49M shares 10-Q · filed 2015-11-09 |
| 2015-08-07 | 414.03M shares 10-Q · filed 2015-08-10 |
| 2015-05-04 | 409.58M shares 10-Q · filed 2015-05-11 |
| 2015-02-23 | 408.84M shares 10-K · filed 2015-03-02 |
| 2014-11-03 | 405.70M shares 10-Q · filed 2014-11-10 |
| 2014-08-04 | 402.38M shares 10-Q · filed 2014-08-11 |
| 2014-05-05 | 388.62M shares 10-Q · filed 2014-05-12 |
| 2014-02-17 | 377.21M shares 10-K · filed 2014-03-03 |
| 2013-11-04 | 357.31M shares 10-Q · filed 2013-11-12 |
| 2013-08-02 | 301.77M shares 10-Q · filed 2013-08-09 |
| 2013-05-03 | 290.88M shares 10-Q · filed 2013-05-10 |
| 2013-03-13 | 289.35M shares 10-K · filed 2013-03-18 |
| 2012-11-05 | 245.78M shares 10-Q · filed 2012-11-09 |
| 2012-08-06 | 199.38M shares 10-Q · filed 2012-08-09 |
| 2012-04-27 | 167.82M shares 10-Q · filed 2012-05-10 |
| 2012-03-02 | 167.47M shares 10-K · filed 2012-03-15 |
| 2011-10-21 | 131.34M shares 10-Q · filed 2011-11-04 |
| 2011-07-22 | 130.97M shares 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |